S&P 500 7,811.54 +0.59%Nasdaq 27,366.17 +0.64%Dow 51,654.95 +0.83%Russell 2000 2,806.98 +0.46%as of 2026-10-09 close
▚ The MicroCap Herald
Micro-cap and nano-cap intelligence, before the crowd
Movers

BIO-key Closed at $3.12 on Sept. 29, Up From $1.68, on 169.6 Million Shares — About 83 Times Its Share Count — After a Gulf Partnership Release With No Financial Terms. By Oct. 9 It Closed at $1.67.

Nasdaq's historical table shows the identity-software company's one-day move came on a Dubai-datelined release about Al Majlis Group that names no contract value. The same day, BIO-key swapped $416,315.80 of a secured note for 247,805 shares; it filed a resale S-1 for 1,236,668 warrant shares on Oct. 9.
Illustrative photograph: computer server and electronics hardware.

BIO-key International (Nasdaq: BKYI) closed at $3.12 on Tuesday, Sept. 29, from $1.68 the session before, on 169,589,500 shares, according to the historical-data table on Nasdaq's site. That is an 86% single-session gain by our arithmetic. The company had 2,035,149 shares of common stock outstanding as of Sept. 30, per the registration statement it filed on Oct. 9, so the day's volume was about 83 times the share count (our arithmetic). The session's range ran from $2.70 to $4.66.

The news that day was a press release, not a filing. Datelined 'Dubai, UAE and Holmdel, NJ — September 29, 2026,' the release says BIO-key 'today announced a strategic partnership with Al Majlis Group, the Dubai-based public affairs and advisory group founded by H.E. Dherar Belhoul Al Falasi.' The two 'will work together to bring BIO-key's identity security platform to government and private sector organizations across the UAE and Saudi Arabia,' and 'the first phase will focus on a joint approach to a select group of priority organizations in the region.'

The release contains no contract value, no revenue expectation, no number of organizations and no timetable beyond that first phase. Al Majlis Group is described in the release's own boilerplate as a firm that 'provides strategic advisory, public affairs and government relations services across the Gulf and emerging markets,' led by a former member of the UAE Federal National Council. It is an advisory and government-relations partner, not a customer or a reseller with a committed order, on the face of the document.

BIO-key was doing something else on Sept. 29 that it disclosed three days later. An 8-K filed Oct. 2 says that on Sept. 29 the company signed four exchange agreements with Streeterville Capital, LLC, holder of a secured promissory note dated Sept. 30, 2025 with an original principal amount of $1,130,000. The parties partitioned four new notes of $68,315.80, $116,000, $117,000 and $115,000, reduced the original note's balance by the $416,315.80 total, and exchanged the partitioned notes 'for an aggregate of 247,805 shares' of common stock. 'As a result of the Exchange Agreements, the Original Note has been paid in full,' the filing says. The issuance relied on the Section 3(a)(9) exemption.

The 8-K does not state a per-share exchange price. Dividing the two figures it does state gives about $1.68 a share (our arithmetic: $416,315.80 over 247,805 shares), which is the Sept. 28 close in Nasdaq's table. The exchanged shares amount to roughly 12% of the Sept. 30 share count (our arithmetic: 247,805 over 2,035,149).

The stock gave the move back over the following eight sessions. Nasdaq's table shows closes of $2.80 on Sept. 30 (2,195,998 shares), $2.29 on Oct. 1, $2.12 on Oct. 2, $1.93 on Oct. 5, $1.82 on Oct. 6, $1.76 on Oct. 7, $1.74 on Oct. 8 and $1.67 on Friday, Oct. 9, the last on 82,529 shares. The Friday close is one cent below where the stock stood before the release.

What BIO-key is: a Holmdel, New Jersey maker of identity and access management software built around what it calls Identity-Bound Biometrics, selling its PortalGuard product on a cloud-hosted or on-premise basis. Its release says the software secures 'access for over forty million users.' Al Majlis's chairman described it in the release as 'a company with more than three decades of experience in securing digital identity.' It executed a 1-for-10 reverse split effective April 30, 2026, according to the cover of its latest 10-Q.

Its last reported quarter was small but improving. The 10-Q for the three months ended June 30, 2026 shows total revenues of $1,919,991, against $1,696,907 a year earlier, and a net loss of $576,852, narrowed from $1,167,396. Six-month revenue was $4,065,524 versus $3,304,066. Cash and cash equivalents were $1,379,300 at June 30, down from $2,694,663 at Dec. 31, 2025, and stockholders' equity was $4,334,878.

The going-concern note is explicit. 'As of the date of this report, the Company does not have enough cash for twelve months of operations,' the 10-Q says. It continues: 'The history of losses, the negative cash flow from operations, and the dependence by the Company on its ability to obtain additional financing to fund its operations after the current cash resources are exhausted raises doubt about the Company's ability to continue as a going concern.' The filing's forward-looking-statements section lists 'our ability to continue as a going concern' among its risks.

The share count has been moving fast. The company reported 1,087,360 shares outstanding as of the July 15 record date for its annual meeting, 1,436,344 as of Aug. 11 on the 10-Q cover, and 2,035,149 as of Sept. 30 in the S-1. Between those dates sits an Aug. 10 warrant exercise agreement, disclosed in an 8-K filed Aug. 13, under which an institutional investor exercised warrants for 618,334 shares after the exercise price was cut from $10.20 to $4.06, producing gross proceeds of approximately $2.51 million, and received new warrants for 1,236,668 shares at $4.06 whose exercise is 'conditioned upon approval of the Company's stockholders.'

That approval is still pending. An 8-K filed Oct. 6 says the annual meeting, first convened Sept. 3 and reconvened Oct. 2, approved the director slate, the auditor and the say-on-pay vote, but was adjourned again on Proposal 4, the Nasdaq Rule 5635(d) vote on the 1,236,668 warrant shares, 'to give stockholders more time to consider and vote.' A total of 606,778 shares, about 55.8% of the 1,087,360 entitled to vote, were represented. The polls on Proposal 4 remain open, and the 8-K says the meeting will be reconvened on Friday, Oct. 30.

The Oct. 9 S-1 registers those 1,236,668 shares for resale by the selling stockholder. It says that, assuming full exercise, the company would have 3,271,817 shares outstanding and would receive 'aggregate gross proceeds of approximately $5,020,872.08.' It also says that, assuming full exercise, the shares offered 'would represent approximately 38% of our outstanding common stock following such exercise.' BIO-key receives nothing from the resale itself.

What is not known: whether the Al Majlis arrangement has produced, or is expected to produce, any contracted revenue; and what drove a volume figure that dwarfs the share count on the day of a release with no numbers in it. The Proposal 4 vote is scheduled to resume at the reconvened meeting on Oct. 30. What is known is that a stock that traded 169.6 million shares in one session now sits where it started, with a going-concern note on file, a warrant overhang that the S-1 says would be about 38% of the post-exercise share count if approved, and a resale registration moving through the SEC.

This article is for general information only and is not investment advice. Figures are as reported by the cited sources at time of writing.

Related coverage